Search

everythinglearnresearchcommunity

for

Search:↓

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Voriconazole can cause serious side effects, especially in long-term use.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Some common medications can harm male fertility, but many effects can be reversed.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Skin grafts are effective for chronic leg ulcers, especially autologous split-thickness grafts for venous ulcers, but more data is needed for diabetic ulcers.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.